Numeric Investors’s Clovis Oncology, Inc. CLVS Stock Holding History

Numeric Investors’s Portfolio CLVS Stock Details CLVS Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2017 Q4	$231K	Sell	3,400 -48,300	-93%	-$3.38M	﹤0.01%	1014
2017 Q3	$4.26M	Buy	+51,700	New	+$4.1M	0.03%	433
2017 Q2	–	Sell	-24,900	Closed	-$1.58M	–	1201
2017 Q1	$1.58M	Buy	24,900 +3,400	+16%	+$207K	0.01%	536
2016 Q4	$955K	Buy	+21,500	New	+$757K	0.01%	674
2016 Q1	–	Sell	-8,563	Closed	-$300K	–	1165
2015 Q4	$300K	Buy	8,563 +5,163	+152%	+$333K	﹤0.01%	865
2015 Q3	$313K	Buy	3,400 +600	+21%	+$51.9K	﹤0.01%	831
2015 Q2	$246K	Buy	+2,800	New	+$240K	﹤0.01%	809
2015 Q1	–	Sell	-48,200	Closed	-$2.7M	–	1081
2014 Q4	$2.7M	Buy	48,200 +400	+0.8%	+$21K	0.03%	317
2014 Q3	$2.17M	Sell	47,800 -97,800	-67%	-$4.09M	0.03%	316
2014 Q2	$6.03M	Buy	+145,600	New	+$7.5M	0.09%	215
2013 Q4	–	Sell	-36,800	Closed	-$2.24M	–	912
2013 Q3	$2.24M	Buy	+36,800	New	+$2.61M	0.04%	323

Other funds holding CLVS

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

PAI

Palo Alto Investors Palo Alto, California $654M AUM 77.8% 1-Year Est. Return

PointState Capital New York $7.9B AUM 42.31% 1-Year Est. Return

Franklin Resources San Mateo, California $408B AUM 30.18% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

OrbiMed New York $5.05B AUM 125.28% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Carmignac Gestion Paris, France $6.51B AUM 19.13% 1-Year Est. Return

Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return

Numeric Investors's CLVS Position: Q4 2017 in Review

Numeric Investors reduced its Clovis Oncology, Inc. (CLVS) stake by 93% in Q4 2017, selling an estimated $3.38M and leaving 3,400 shares worth $231K. The position accounts for ﹤0.01% of the portfolio, ranked #1014.

Numeric Investors first reported a position in CLVS in Q3 2013 and has held it in 11 quarters since. The position peaked at $6.03M in Q2 2014. 247 funds tracked by Wall St. Rank hold CLVS as of Q4 2017.

Numeric Investors held 3,400 shares of Clovis Oncology, Inc. worth $231K as of Q4 2017.
Numeric Investors sold 48,300 Clovis Oncology, Inc. shares in Q4 2017, an estimated $3.38M.
Clovis Oncology, Inc. made up ﹤0.01% of Numeric Investors's portfolio in Q4 2017, its #1014 holding.
Numeric Investors first reported a position in Clovis Oncology, Inc. in Q3 2013 and has held it in 11 quarters since.
Numeric Investors's Clovis Oncology, Inc. position peaked at $6.03M in Q2 2014.
247 funds tracked by Wall St. Rank held Clovis Oncology, Inc. as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.